iRhythm Technologies (IRTC)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of iRhythm Technologies (IRTC)
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.
Key Insights
Critical company metrics and information
Share Price
$85.18Market Cap
$2.67 BillionTotal Outstanding Shares
31.30 Million SharesTotal Employees
2,000Dividend
No dividendIPO Date
October 20, 2016SIC Description
Surgical & Medical Instruments & ApparatusHomepage
https://www.irhythmtech.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow | $480.62 Million |
Net Cash Flow From Operating Activities | $-31.81 Million |
Net Cash Flow From Financing Activities | $511.86 Million |
Net Cash Flow From Investing Activities | $576000.00 |
Net Cash Flow From Financing Activities, Continuing | $511.86 Million |
Net Cash Flow From Operating Activities, Continuing | $-31.81 Million |
Net Cash Flow From Investing Activities, Continuing | $576000.00 |
Net Cash Flow, Continuing | $480.62 Million |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Operating Income/Loss | $-150.60 Million |
Diluted Average Shares | $93.50 Million |
Depreciation and Amortization | $20.34 Million |
Income/Loss From Continuing Operations Before Tax | $-149.99 Million |
Income/Loss From Continuing Operations After Tax | $-150.66 Million |
Net Income/Loss Attributable To Parent | $-150.66 Million |
Diluted Earnings Per Share | $4.86 |
Revenues | $560.02 Million |
Net Income/Loss | $-150.66 Million |
Costs And Expenses | $710.01 Million |
Net Income/Loss Available To Common Stockholders, Basic | $-150.66 Million |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Operating Expenses | $530.49 Million |
Cost Of Revenue | $180.14 Million |
Basic Average Shares | $93.50 Million |
Benefits Costs and Expenses | $710.01 Million |
Gross Profit | $379.89 Million |
Selling, General, and Administrative Expenses | $418.91 Million |
Basic Earnings Per Share | $4.86 |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Income Tax Expense/Benefit | $669000.00 |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Current Assets | $627.91 Million |
Liabilities | $837.92 Million |
Other Current Assets | $447.41 Million |
Assets | $909.69 Million |
Noncurrent Liabilities | $737.82 Million |
Current Liabilities | $100.10 Million |
Noncurrent Assets | $281.78 Million |
Liabilities And Equity | $909.69 Million |
Fixed Assets | $122.39 Million |
Other Non-current Assets | $159.39 Million |
Inventory | $15.03 Million |
Equity Attributable To Parent | $71.77 Million |
Equity | $71.77 Million |
Cash | $165.46 Million |
Equity Attributable To Noncontrolling Interest | $0.00 |
Other Current Liabilities | $92.51 Million |
Accounts Payable | $7.59 Million |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.